{"count": 3, "results": [{"_id": "30225697", "pmid": 30225697, "title": "Antidiabetic Activity of Afobazole in Wistar Rats.", "journal": "Bull Exp Biol Med", "authors": ["Ostrovskaya RU", "Ivanov SV", "Voronin MV", "Ozerova IV", "Zolotov NN", "Seredenin SB"], "date": "2018-09-01T00:00:00Z", "doi": "10.1007/s10517-018-4233-4", "meta_date_publication": "2018 Sep", "meta_volume": "165", "meta_issue": "5", "meta_pages": "649-652", "score": 50055.43, "text_hl": "Using the @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@ model of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ in Wistar @SPECIES_10116 @@@rats@@@, we compared antidiabetic activity of anxiolytic @CHEMICAL_2_((2_morpholino)ethylthio)_5_ethoxybenzimidazole @CHEMICAL_MESH:C410924 @@@Afobazole@@@ with that of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. @CHEMICAL_2_((2_morpholino)ethylthio)_5_ethoxybenzimidazole @CHEMICAL_MESH:C410924 @@@Afobazole@@@ in a dose of 10 mg/kg reduced @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@-induced @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and @DISEASE_Hyperphagia @DISEASE_MESH:D006963 @@@polyphagia@@@ and prevented accumulation of @CHEMICAL_Malondialdehyde @CHEMICAL_MESH:D008315 @@@malonic dialdehyde@@@, being not inferior to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in a dose of 300 mg/kg, and was even more effective than @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in body weight recovery, elimination of @<m>DISEASE_Polydipsia</m> @DISEASE_MESH:D059606 @@@polydipsia@@@, and preservation of these effects after treatment withdrawal.", "citations": {"NLM": "Ostrovskaya RU, Ivanov SV, Voronin MV, Ozerova IV, Zolotov NN, Seredenin SB. Antidiabetic Activity of Afobazole in Wistar Rats. Bull Exp Biol Med. 2018 Sep;165(5):649-652. PMID: 30225697", "BibTeX": "@article{30225697, title={Antidiabetic Activity of Afobazole in Wistar Rats.}, author={Ostrovskaya RU and Ivanov SV and Voronin MV and Ozerova IV and Zolotov NN and Seredenin SB}, journal={Bull Exp Biol Med}, volume={165}, number={5}, pages={649-652}}"}}, {"_id": "20425675", "pmid": 20425675, "title": "[Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes].", "journal": "Dtsch Med Wochenschr", "authors": ["Kress S"], "date": "2010-05-01T00:00:00Z", "doi": "10.1055/s-0030-1253676", "meta_date_publication": "2010 May", "meta_volume": "135", "meta_issue": "18", "meta_pages": "907-10", "score": 50046.02, "text_hl": "[Sequential treatment with @GENE_INS @GENE_3630 @@@insulin@@@ glargine and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@exenatide@@@ in a @SPECIES_9606 @@@patient@@@ with newly diagnosed @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type-2 diabetes@@@].", "citations": {"NLM": "Kress S. [Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes]. Dtsch Med Wochenschr. 2010 May;135(18):907-10. PMID: 20425675", "BibTeX": "@article{20425675, title={[Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes].}, author={Kress S}, journal={Dtsch Med Wochenschr}, volume={135}, number={18}, pages={907-10}}"}}, {"_id": "22644981", "pmid": 22644981, "title": "Combination exenatide-sitagliptin therapy used with glipizide in a patient with type 2 diabetes mellitus.", "journal": "Am J Health Syst Pharm", "authors": ["Patel MB", "Elmore LK", "Edgerton LP", "Whalin LM"], "date": "2012-06-15T00:00:00Z", "doi": "10.2146/ajhp110567", "meta_date_publication": "2012 Jun 15", "meta_volume": "69", "meta_issue": "12", "meta_pages": "1044-8", "score": 50039.715, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ was later discontinued due to elevated liver function test values. ", "citations": {"NLM": "Patel MB, Elmore LK, Edgerton LP, Whalin LM. Combination exenatide-sitagliptin therapy used with glipizide in a patient with type 2 diabetes mellitus. Am J Health Syst Pharm. 2012 Jun 15;69(12):1044-8. PMID: 22644981", "BibTeX": "@article{22644981, title={Combination exenatide-sitagliptin therapy used with glipizide in a patient with type 2 diabetes mellitus.}, author={Patel MB and Elmore LK and Edgerton LP and Whalin LM}, journal={Am J Health Syst Pharm}, volume={69}, number={12}, pages={1044-8}}"}}]}